Enrique José
Andreu Oltra
Profesional Investigador
Centro de Investigación Médica Aplicada
Pamplona, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigación Médica Aplicada (8)
2021
2017
-
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Journal of Translational Medicine, Vol. 15, Núm. 1
-
Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
Translational Research, Vol. 188, pp. 80-91.e2
2016
-
Generation and characterization of human iPSC line generated from mesenchymal stem cells derived from adipose tissue
Stem Cell Research, Vol. 16, Núm. 1, pp. 20-23
2011
-
MAPC transplantation confers a more durable benefit than AC133+ cell transplantation in severe hind limb ischemia
Cell Transplantation, Vol. 20, Núm. 2, pp. 259-269
2010
-
Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and-resistant Bcr-Abl1-expressing cells
Oncogene, Vol. 29, Núm. 22, pp. 3276-3286
2008
-
Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation
Leukemia Research, Vol. 32, Núm. 5, pp. 709-716
2006
-
Somatic stem cells and the origin of cancer
Clinical and Translational Oncology, Vol. 8, Núm. 9, pp. 647-663